Financials Médica Sur, S.A.B. de C.V.
Equities
MEDICA B
MXP510121215
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
40.95 MXN | -0.12% | +0.86% | +0.79% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Capitalization 1 | 186.2 | 125 | 192.5 | 241.2 | 241.2 | - |
Enterprise Value (EV) 1 | 186.2 | 187.2 | 182 | 234.2 | 249.6 | 251.1 |
P/E ratio | - | - | - | - | - | - |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 1.12 x | 0.69 x | 0.99 x | 1.05 x | 1.04 x | 1 x |
EV / Revenue | 1.12 x | 0.69 x | 0.99 x | 1.05 x | 1.04 x | 1 x |
EV / EBITDA | 6.18 x | 3.63 x | 5.11 x | 4.79 x | 4.98 x | 4.73 x |
EV / FCF | - | - | 45,531,071 x | - | - | 10,173,838 x |
FCF Yield | - | - | 0% | - | - | 0% |
Price to Book | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 123,270 | 123,270 | 107,939 | 107,939 | 107,939 | - |
Reference price 2 | 34.00 | 21.49 | 37.20 | 40.95 | 40.95 | 40.95 |
Announcement Date | 2/26/19 | 2/21/20 | 4/17/23 | 2/23/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net sales 1 | 165.9 | 180.5 | - | 195.2 | 222.8 | 232.3 | 241.3 |
EBITDA 1 | 30.13 | 34.46 | - | 37.67 | 48.89 | 48.45 | 50.98 |
EBIT 1 | - | 17.51 | - | 29.03 | 39.25 | 38.41 | 40.17 |
Operating Margin | - | 9.7% | - | 14.87% | 17.61% | 16.54% | 16.64% |
Earnings before Tax (EBT) 1 | - | - | - | 34.19 | 40.01 | 37.92 | 39.78 |
Net income 1 | - | - | 59.04 | 47.93 | 34.26 | 26.56 | 27.87 |
Net margin | - | - | - | 24.56% | 15.38% | 11.43% | 11.55% |
EPS | - | - | - | - | - | - | - |
Free Cash Flow | - | - | - | 4.227 | - | - | 23.7 |
FCF margin | - | - | - | 2.17% | - | - | 9.82% |
FCF Conversion (EBITDA) | - | - | - | 11.22% | - | - | 46.5% |
FCF Conversion (Net income) | - | - | - | 8.82% | - | - | 85.04% |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 2/26/19 | 2/21/20 | 2/21/22 | 4/17/23 | 2/23/24 | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net Debt | - | 62.2 | - | - | - | 8.4 | 9.99 |
Net Cash position | - | - | - | 10.5 | - | - | - |
Leverage (Debt/EBITDA) | - | 1.806 x | - | - | - | 0.1733 x | 0.1959 x |
Free Cash Flow | - | - | - | 4.23 | - | - | 23.7 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex | - | - | - | - | - | - | 15 |
Capex / Sales | - | - | - | - | - | - | 6.21% |
Announcement Date | 2/26/19 | 2/21/20 | 2/21/22 | 4/17/23 | 2/23/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.79% | 260M | |
+13.70% | 81.4B | |
-29.20% | 70.18B | |
+9.72% | 29.08B | |
-11.43% | 16.97B | |
-0.43% | 16.96B | |
-0.31% | 15.26B | |
+3.42% | 12.41B | |
-30.70% | 11.95B | |
-6.75% | 11.93B |
- Stock Market
- Equities
- MEDICA B Stock
- Financials Médica Sur, S.A.B. de C.V.